RDNT

Business Context and Reporting Period

Company: RadNet, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2010
Business Overview: RadNet is the leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2010, the company operated 201 centers across California, Delaware, Maryland, New Jersey, Florida, and New York. Services include MRI, CT, PET, nuclear medicine, mammography, ultrasound, and X-ray. The company utilizes a multi-modality strategy to diversify revenue streams.

Key Financial Metrics

Note: The 2010 Net Loss includes a $9.9 million non-cash loss on extinguishment of debt related to refinancing.

Material Changes vs. Prior Period

• Revenue Growth: Net revenue increased 4.6% to $548.5 million, driven primarily by acquisitions ($51.3 million from centers acquired after Jan 1, 2009). Comparable center revenue decreased 3.2% due to severe weather in Q1 2010 and a broad economic slowdown reducing patient visits.
• Operating Expenses: Increased 5.1% to $510.1 million. Salaries and professional reading fees rose 7.8%, while medical supplies decreased 6.4% due to vendor changes and rebates.
• Debt Refinancing: On April 6, 2010, the company completed a $585 million debt refinancing, replacing prior credit facilities with a new senior secured term loan ($285 million), a revolving credit facility ($100 million), and senior unsecured notes ($200 million). This resulted in a $9.9 million loss on extinguishment of debt.
• Acquisitions: Significant acquisitions in 2010 included Image Medical Corporation (parent of eRAD, Inc.) for approximately $10.7 million (cash and note) and Truxtun Medical Group for approximately $21.5 million (cash and stock).

Guidance, Outlook, and Risks

Management Commentary: Management expects to continue the trend of reducing net losses and aims to begin generating net income. The company is focusing on maximizing performance at existing facilities, optimizing operating efficiencies, and expanding networks through disciplined acquisitions.

Key Risks and Contingencies:

• Regulatory Environment: Significant exposure to changes in Medicare reimbursement rates (e.g., Deficit Reduction Act caps, PPACA changes to utilization factors) and potential enforcement of Anti-Kickback and Stark Laws.
• Debt Obligations: The company is highly leveraged with $504.6 million in total indebtedness. Covenants restrict dividends, additional indebtedness, and asset sales. Failure to meet covenants could lead to acceleration of debt.
• Key Personnel: Operations rely heavily on Dr. Howard G. Berger (CEO) and his relationship with Beverly Radiology Medical Group (BRMG), which provides professional services at 91 California facilities.
• Economic Conditions: Continued economic uncertainty and unemployment rates may impact patient volumes and reimbursement collections.

Investor Verification Checklist

• Debt Covenants: Verify compliance with the minimum interest coverage ratio and maximum total leverage ratio under the New Credit Agreement.
• Reimbursement Rates: Monitor legislative updates regarding Medicare Physician Fee Schedule conversion factors and the implementation of PPACA utilization rate adjustments.
• BRMG Relationship: Assess the stability of the management agreement with Beverly Radiology Medical Group, which is critical for California operations.
• Integration of eRAD: Evaluate the successful integration of the eRAD acquisition and the realization of expected synergies in the new Radiology Information Technology division.
• Cash Flow: Review the ability to generate sufficient cash flow from operations to service the $504.6 million debt load and fund capital expenditures.